Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
472,067,564
-
Share change
-
+17,030,518
-
Total reported value
-
$24,920,431,379
-
Put/Call ratio
-
52%
-
Price per share
-
$52.84
-
Number of holders
-
762
-
Value change
-
+$989,421,387
-
Number of buys
-
325
-
Number of sells
-
387
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q1 2014
As of 31 Mar 2014,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) was held by
762 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
472,067,564 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, Capital Research Global Investors, WELLINGTON MANAGEMENT CO LLP, FMR LLC, Mondrian Investment Partners LTD, Invesco Ltd., Allianz Asset Management AG, BARROW HANLEY MEWHINNEY & STRAUSS LLC, PointState Capital LP, and SOROS FUND MANAGEMENT LLC.
This page lists
762
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.